针对Neumora Therapeutics， Inc. (NMRA)提起的集体诉讼，寻求为投资者追回损失 -联系Levi & Korsinsky律师事务所-动脉网

Class Action Filed Against Neumora Therapeutics, Inc. (NMRA) Seeking Recovery for Investors - Contact Levi & Korsinsky

CISION 等信源发布 2025-03-04 18:45



可切换为仅中文







NEW YORK

纽约

，

March 4, 2025

2025年3月4日

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in

/PRNewswire/ -- Levi & Korsinsky, LLP 通知投资者

Neumora Therapeutics, Inc.

纽莫拉治疗公司

('Neumora Therapeutics, Inc.' or the 'Company') (NASDAQ:

('Neumora Therapeutics, Inc.' 或 '公司') (NASDAQ:

NMRA

) of a class action securities lawsuit.

) 一项集体诉讼证券诉讼。

CLASS DEFINITION:

类定义：

The lawsuit seeks to recover losses on behalf of Neumora Therapeutics, Inc. investors who were adversely affected by

该诉讼旨在为受到不利影响的Neumora Therapeutics, Inc.投资者追回损失，

alleged

涉嫌的

securities

证券

fraud

欺诈

. This lawsuit is on behalf of a class of all persons or entities who purchased or otherwise acquired Neumora common stock pursuant and/or traceable to the Offering Documents, commenced on or about

本诉讼代表所有根据和/或可追溯到发行文件购买或以其他方式获得Neumora普通股的个人或实体，于大约某日提起。

September 15, 2023

2023年9月15日

. Follow the link below to get more information and be contacted by a member of our team:

点击下面的链接获取更多信息，并由我们团队的成员与您联系：

https://zlk.com/pslra-1/neumora-therapeutics-inc-lawsuit-submission-form?prid=133513&wire=4

NMRA

investors may also contact

投资者也可以联系

Joseph E. Levi, Esq.

约瑟夫·E·列维，律师

via email

通过电子邮件

at jlevi@levikorsinsky.com or

至 jlevi@levikorsinsky.com 或

by telephone at (212) 363-7500.

通过电话拨打 (212) 363-7500。

CASE DETAILS:

案件详情：

The filed complaint

提交的投诉

alleges

声称

that defendants made false statements and/or concealed that: (1) in order for Neumora to justify conducting its Phase Three Program, Neumora was forced to amend BlackThorn's original Phase Two trial inclusion criteria to include a patient population with moderate to severe Major Depressive Disorder, MDD, to show that Navacaprant, Neumora's flagship therapeutic candidate, offered a statistically significant improvement in treating MDD; (2) and to that same end, the Company also added a prespecified analysis to the Phase Two statistical analysis plan, focusing on patients suffering from moderate to severe MDD; and (3) the Phase Two Trials lacked adequate data, particularly in regards to the patient population size and the ratio of male to female patients within the patient population, to be able to accurately predict the results of the KOASTAL-1 study..

被告作出虚假陈述和/或隐瞒了以下事实：(1) 为了使Neumora能够为其第三阶段计划提供依据，Neumora被迫修改了BlackThorn最初的第二阶段试验纳入标准，以包括中度至重度重度抑郁症（MDD）的患者群体，从而证明Navacaprant（Neumora的旗舰治疗候选药物）在治疗MDD方面具有统计学上的显著改善；(2) 出于相同目的，公司还在第二阶段的统计分析计划中增加了一项预先设定的分析，重点关注中度至重度MDD患者；(3) 第二阶段试验缺乏足够的数据，尤其是在患者群体规模以及患者群体中男性与女性比例方面，无法准确预测KOASTAL-1研究的结果。

WHAT'S NEXT?

接下来是什么？

If you suffered a loss in Neumora Therapeutics, Inc. during the relevant time frame, you have until

如果您在相关时间段内在Neumora Therapeutics, Inc.遭受了损失，您必须在

April 7, 2025

2025年4月7日

to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

要求法院任命您为主导原告。您分享任何赔偿的能力并不需要您担任主导原告。

NO COST TO YOU:

无需您承担费用：

If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees.

如果您是班级成员，您可能有权获得赔偿，而无需支付任何自付费用或费用。

There is no cost or obligation to participate.

参与无需费用或义务。

WHY LEVI & KORSINSKY:

为什么选择LEVI & KORSINSKY:

Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients.

在过去的 20 年里，Levi & Korsinsky 律所团队已为权益受损的股东争取到数亿美元的赔偿，并建立了赢得高风险案件的良好记录。本所拥有广泛的专业知识，代表投资者处理复杂的证券诉讼案件，并拥有超过 70 名员工组成的团队为客户提供服务。

For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in .

七年蝉联，Levi & Korsinsky在ISS证券集体诉讼服务的Top 50报告中位列顶级证券诉讼公司之一。

the United States

美国

。

CONTACT:

联系人：

Levi & Korsinsky, LLP

Levi & Korsinsky律师事务所

Joseph E. Levi, Esq.

约瑟夫·E·列维，律师

Ed Korsinsky, Esq.

埃德·科辛斯基，律师